FDAnews
www.fdanews.com/articles/189079-teleflex-gains-japanese-approval-for-urolift-system

Teleflex Gains Japanese Approval for Urolift System

November 7, 2018

NeoTract, a Teleflex subsidiary, received approval from Japan’s Ministry of Health, Labor and Welfare for its Urolift system intended for benign prostatic hyperplasia treatment.

In the common and treatable urinary condition, also known as prostate gland enlargement, the prostate enlarges and surrounds part of the urethra.

Teleflex’s system uses a minimally invasive procedure that places tiny devices in the urethra to reopen the lower urinary tract by moving tissue blockage away from the enlarged prostate.

View today's stories